DeepMed Research

SWOG

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1956-01-01

Employees: 101

Market Cap: -

Website: http://www.swog.org

Clinical Trials

S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follicular Lymphoma

Completed

Conditions: Lymphoma

First Posted Date: 2010-05-26

Last Posted Date: 2014-05-09

Lead Sponsor: SWOG Cancer Research Network

Target Recruit Count: 196

Registration Number: NCT01131221

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Phase 3

Active, not recruiting

Conditions: Kidney Cancer

Interventions: Other: placebo
Drug: everolimus

First Posted Date: 2010-05-10

Last Posted Date: 2024-08-29

Lead Sponsor: SWOG Cancer Research Network

Target Recruit Count: 1545

Registration Number: NCT01120249

Locations: 🇺🇸
Greenville Health System Cancer Institute-Easley, Easley, South Carolina, United States
🇺🇸
The Mark H Zangmeister Center, Columbus, Ohio, United States
🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

and more 988 locations

S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin

Completed

Conditions: Prostate Cancer

First Posted Date: 2010-05-10

Last Posted Date: 2016-10-07

Lead Sponsor: SWOG Cancer Research Network

Target Recruit Count: 545

Registration Number: NCT01120262

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer

Not Applicable

Completed

Conditions: brca2 Mutation Carrier
Breast Cancer
brca1 Mutation Carrier

Interventions: Dietary Supplement: cholecalciferol
Other: placebo

First Posted Date: 2010-04-01

Last Posted Date: 2017-11-24

Lead Sponsor: SWOG Cancer Research Network

Target Recruit Count: 208

Registration Number: NCT01097278

Locations: 🇺🇸
Saint Mary Corwin Medical Center, Pueblo, Colorado, United States
🇺🇸
Memorial Hospital of South Bend, South Bend, Indiana, United States
🇺🇸
Great Falls Clinic, Great Falls, Montana, United States

and more 357 locations

S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)

Phase 3

Completed

Conditions: Helicobacter Pylori Infection

Interventions: Drug: PACx14
Drug: PACMx5
Drug: PAx5/PCMx5

First Posted Date: 2010-02-03

Last Posted Date: 2012-09-26

Lead Sponsor: SWOG Cancer Research Network

Target Recruit Count: 1859

Registration Number: NCT01061437

Locations: 🇨🇴
Universidad del Valle, Cali, Valle, Colombia
🇨🇷
Fundacion Inciensa, San Jose, Costa Rica
🇲🇽
Instituto Technologico de Sonora, Obregon, Sonora, Mexico

and more 4 locations

S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia

Completed

Conditions: Leukemia

First Posted Date: 2010-02-01

Last Posted Date: 2015-03-06

Lead Sponsor: SWOG Cancer Research Network

Target Recruit Count: 357

Registration Number: NCT01059734

S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Phase 2

Withdrawn

Conditions: Multiple Myeloma
Plasma Cell Myeloma

Interventions: Drug: bortezomib
Drug: cisplatin
Drug: cyclophosphamide
Drug: dexamethasone
Drug: doxorubicin hydrochloride
Drug: etoposide
Drug: lenalidomide
Drug: melphalan
Drug: thalidomide
Genetic: gene expression analysis
Genetic: microarray analysis
Other: laboratory biomarker analysis
Procedure: autologous-autologous tandem hematopoietic stem cell transplantation

First Posted Date: 2010-01-25

Last Posted Date: 2015-03-06

Lead Sponsor: SWOG Cancer Research Network

Registration Number: NCT01055301

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States
🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸
Group Health Central Hospital, Seattle, Washington, United States

and more 18 locations

S0916, MLN1202 in Treating Patients With Bone Metastases

Phase 2

Completed

Conditions: Metastatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: anti-CCR2 monoclonal antibody MLN1202
Genetic: polymorphism analysis
Other: laboratory biomarker analysis

First Posted Date: 2009-11-18

Last Posted Date: 2018-08-09

Lead Sponsor: SWOG Cancer Research Network

Target Recruit Count: 44

Registration Number: NCT01015560

Locations: 🇺🇸
Reid Hospital & Health Care Services, Richmond, Indiana, United States
🇺🇸
Cancer Center of Kansas, PA - Dodge City, Dodge City, Kansas, United States
🇺🇸
Cancer Center of Kansas, PA - Wichita, Wichita, Kansas, United States

and more 44 locations

SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

Completed

Conditions: Lymphoma

First Posted Date: 2009-10-23

Last Posted Date: 2013-05-20

Lead Sponsor: SWOG Cancer Research Network

Target Recruit Count: 939

Registration Number: NCT01000558

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸
Group Health Central Hospital, Seattle, Washington, United States
🇺🇸
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle, Washington, United States

and more 200 locations

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Completed

Conditions: Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

First Posted Date: 2009-10-16

Last Posted Date: 2015-03-06

Lead Sponsor: SWOG Cancer Research Network

Target Recruit Count: 3341

Registration Number: NCT00996047

Locations: 🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
Harborview Medical Center, Seattle, Washington, United States
🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

and more 277 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy